• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非 B 非 C 型肝细胞癌的临床病理分析,重点关注细胞增殖。

Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation.

机构信息

Department of Pathology, Kurume University School of Medicine, Kurume, Japan

Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.

出版信息

Anticancer Res. 2022 Jan;42(1):449-457. doi: 10.21873/anticanres.15503.

DOI:10.21873/anticanres.15503
PMID:34969755
Abstract

BACKGROUND/AIM: Non-B non-C hepatocellular carcinomas (NBNC-HCCs) are larger than hepatitis virus-related HCCs. We conducted a clinicopathological study of patients who underwent curative NBNC-HCC resection, including proliferative activity assessments, such as nuclear grade and Ki-67 labelling index (LI).

MATERIALS AND METHODS

Histopathological findings of 197 patients were examined, including 56 NBNC-HCCs, 45 hepatitis B virus (HBV)-related HCCs (HBV-HCC), and 96 hepatitis C virus (HCV)-related HCCs (HCV-HCC).

RESULTS

NBNC-HCCs were significantly larger than HCV-HCCs, but not significantly different from HBV-HCCs. Mitotic counts, nuclear grade, and Ki-67 LI of NBNC-HCCs were not significantly different from those of HCV-HCCs, but were significantly lower than those of HBV-HCCs. Recurrence-free survival was significantly better in the NBNC-HCC group than in the HBV-HCC group in cases with mild liver fibrosis.

CONCLUSION

NBNC-HCCs were significantly larger in diameter, but their nuclear grade or Ki-67 LI were not significantly different from those of other HCCs, suggesting that they do not have a higher proliferative activity.

摘要

背景/目的:非乙型肝炎、非丙型肝炎肝细胞癌(NBNC-HCC)比乙型肝炎病毒相关 HCC 更大。我们对接受根治性 NBNC-HCC 切除术的患者进行了临床病理研究,包括核级和 Ki-67 标记指数(LI)等增殖活性评估。

材料和方法

检查了 197 例患者的组织病理学发现,包括 56 例 NBNC-HCC、45 例乙型肝炎病毒(HBV)相关 HCC(HBV-HCC)和 96 例丙型肝炎病毒(HCV)相关 HCC(HCV-HCC)。

结果

NBNC-HCC 明显大于 HCV-HCC,但与 HBV-HCC 无显著差异。NBNC-HCC 的有丝分裂计数、核级和 Ki-67 LI 与 HCV-HCC 无显著差异,但明显低于 HBV-HCC。在轻度肝纤维化的情况下,NBNC-HCC 组的无复发生存率明显优于 HBV-HCC 组。

结论

NBNC-HCC 的直径明显更大,但核级或 Ki-67 LI 与其他 HCC 无显著差异,表明其增殖活性并不高。

相似文献

1
Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation.非 B 非 C 型肝细胞癌的临床病理分析,重点关注细胞增殖。
Anticancer Res. 2022 Jan;42(1):449-457. doi: 10.21873/anticanres.15503.
2
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.比较 HBV 阳性、HCV 阳性和非 B 非 C 型肝细胞癌患者的手术治疗效果:一项全国性的 11950 例患者研究。
Ann Surg. 2015 Mar;261(3):513-20. doi: 10.1097/SLA.0000000000000821.
3
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.乙型肝炎病毒既往感染在日本HBs抗原阴性及抗-HCV阴性肝细胞癌患者中的作用:病因学及分子生物学研究
J Exp Clin Cancer Res. 1999 Sep;18(3):379-89.
4
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.在没有乙型肝炎或丙型肝炎的肝细胞癌患者中,早期纤维化但晚期肿瘤分期和更差的结局。
Dig Dis Sci. 2020 Jul;65(7):2120-2129. doi: 10.1007/s10620-019-05938-3. Epub 2019 Nov 13.
5
Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.非B非C型肝细胞癌患者的术后结局:对有乙型肝炎感染史患者的亚组分析
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1034-40. doi: 10.1245/s10434-015-4845-0. Epub 2015 Sep 8.
6
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.增殖标志物Ki-67和p53蛋白在HBV或HCV肝硬化中的肝脏表达与发育异常肝细胞变化及肝细胞癌的关系。
J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x.
7
Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.半年一次的影像监测与非B、非C型肝细胞癌患者更好的生存率相关。
Mediators Inflamm. 2015;2015:687484. doi: 10.1155/2015/687484. Epub 2015 Sep 30.
8
Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.与显性乙型肝炎病毒相关性肝细胞癌相比,HBcAb 阳性非 B 非 C 型肝细胞癌患者肝切除术后的结局。
Clin Transl Oncol. 2020 Mar;22(3):401-410. doi: 10.1007/s12094-019-02141-8. Epub 2019 Jun 6.
9
Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.HBsAg阴性和HCV阴性肝细胞癌患者临床特征与肝组织中乙型肝炎病毒X基因检测的相关性
Liver. 2002 Oct;22(5):374-9. doi: 10.1034/j.1600-0676.2002.01645.x.
10
Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome.非B非C型肝细胞癌患者的临床病理特征:特别提及代谢综合征
Hepatogastroenterology. 2014 Jan-Feb;61(129):129-35.

引用本文的文献

1
Association of PNPLA3 SNP With the Development of HBV-related Hepatocellular Carcinoma.载脂蛋白 L3 单核苷酸多态性与乙型肝炎病毒相关肝细胞癌发展的相关性研究。
In Vivo. 2023 Mar-Apr;37(2):763-770. doi: 10.21873/invivo.13139.